Concepedia

Publication | Open Access

Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance

DOIFull Paper Access

67

Citations

40

References

2014

Year

Daniele Cretella, Francesca Saccani, Federico Quaini, Caterina Frati, Costanza Annamaria Lagrasta, Mara Bonelli, Cristina Caffarra, Andrea Cavazzoni, Claudia Fumarola, Maricla Galetti,
Molecular Cancer

References

YearCitations

Page 1